USA-based immunotherapy specialist SAB Biotherapeutics has announced the closing of an underwritten public offering, ...

Swiss pharma giant Novartis today announced that it has entered into an agreement with Synnovation Therapeutics to acquire ...

Fauna Bio, a specialist in the use of extreme mammal biology and comparative genomics, has announced the designation of a target under its strategic obesity discovery collaboration with Eli Lilly that ...

US-German biotech Galimedix Therapeutics has unveiled preclinical data for a next-generation oral Alzheimer’s candidate, pointing to improved pharmacokinetics that could support lower dosing and more ...

Indian drugmaker Glenmark Pharmaceuticals has announced the introduction of two generic products to the US market.

US biotech Azitra (NYSE American: AZTR) has secured financing of up to $31.4 million, combining an initial $10.5 million raise with a further $20.9 million tied to warrant exercises. The deal is ...

A group of Senate Democrats has set out an expansive healthcare reform agenda, targeting rising insurance costs and insurer profits while positioning the effort as a response to recent Republican-led ...

UK pharma major GSK has announced that the US Food and Drug Administration (FDA) has approved Lynavoy (linerixibat) for the treatment of cholestatic pruritus in adult patients with PBC.

Montreal, Canada-based Congruence Therapeutics, a clinical-stage, computationally-driven biotechnology company building a unique pipeline of pharmacological correctors for diseases of protein ...

Danish pharma major Novo Nordisk late Thursday announced that the US Food and Drug Administration (FDA) has approved Wegovy HD (once-weekly injectable semaglutide 7.2mg) to reduce excess body weight ...

The UK’s National Institute for Health and Care Excellence (NICE) has published a successful outcome for Eli Lilly’s appeal against final draft guidance which does not recommend National Health ...

US drugmaker Collegium Pharmaceutical has agreed to buy Corium Therapeutics' attention deficit hyperactivity disorder (ADHD) drug Azstarys (serdexmethylphenidate and dexmethylphenidate) for $650 ...